Medplus Health Services Ltd - Stock Valuation and Financial Performance

BSE: 543427 | NSE: MEDPLUS | Pharmaceuticals & Drugs | Small Cap

Medplus Health Servi Share Price

689.45 4.90 0.72%
as on 28-Mar'24 13:30

DeciZen - make an informed investing decision on Medplus Health Servi

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Semi Strong

Medplus Health Services stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
8,182.9 Cr.
52-wk low:
598
52-wk high:
977.5

Is Medplus Health Services Ltd an attractive stock to invest in?

1. Is Medplus Health Services Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Medplus Health Services Ltd is a below average quality company.

2. Is Medplus Health Services Ltd undervalued or overvalued?

The key valuation ratios of Medplus Health Services Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Medplus Health Services Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Medplus Health Services Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Medplus Health Servi:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Medplus Health Services Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -2.2%-2%-2.5%-1.3%-4.6%-1.4%-0.7%-1.8%0.9%0.9%-
Value Creation
Index
-1.2-1.2-1.2-1.1-1.3-1.1-1.1-1.1-0.9-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2.62.42.22.29.49.561.168.3146214406
Sales YoY Gr.--6.6%-6.3%-3.6%336.1%1.1%541.9%11.8%113.3%46.8%-
Adj EPS -24.1-20.7-22.7-10.3-70.6-11.2-9.9-37.40.50.50.5
YoY Gr.-NANANANANANANANA2.2%-
BVPS (₹) 689.9634.6542.6437.3821.2809.11,772.82,09392.393.196.8
Adj Net
Profit
-4.6-3.9-4.3-2-16.2-2.6-2.3-8.65.55.75
Cash Flow from Ops. -1.8-4.7-4.2-1.7-1.1-0.92.9-6.2-18.411.4-
Debt/CF from Ops. -4.5-9.2-10.2-25.3000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 63.5%86.7%51.8%46.8%
Adj EPS NANANA2.2%
BVPS-20%-35.3%-62.6%0.9%
Share Price - - - 4.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-3.3-2.9-3.3-1.8-11.3-1.4-0.8-1.90.70.50.5
Op. Profit
Mgn %
-59.5-137.1-223.9-89.3-51.6-36.411.7-12.92.33.17.6
Net Profit
Mgn %
-178.4-164-191.8-90.1-171.5-27-3.7-12.53.72.61.3
Debt to
Equity
0.10.30.40.5000000-
Working Cap
Days
2593847067941541566111680757777
Cash Conv.
Cycle
-50-15-4-39-72-1572267383950

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 0.50%

Sales growth is growing at healthy rate in last 3 years 51.84%

Sales growth is good in last 4 quarters at 144.65%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Medplus Health Services Ltd.

Standalone Consolidated
TTM EPS (₹) 0.5 4.9
TTM Sales (₹ Cr.) 406 5,387
BVPS (₹.) 96.8 128.9
Reserves (₹ Cr.) 1,133 1,517
P/BV 7.07 5.31
PE 0.00 139.50
From the Market
52 Week Low / High (₹) 597.95 / 977.45
All Time Low / High (₹) 570.00 / 1343.00
Market Cap (₹ Cr.) 8,183
Equity (₹ Cr.) 23.9
Face Value (₹) 2
Industry PE 47.8

Management X-Ray of Medplus Health Servi:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *26.9126.9153.8150.5350.5350.5350.5350.5358.05
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Medplus Health Servi

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales32229106168146214
Operating Expenses 467414138677142208
Manufacturing Costs2111122014
Material Costs0000004450119157
Employee Cost 1332447231428
Other Costs 123298344919
Operating Profit -2-3-5-2-5-3-25-936
Operating Profit Margin (%) -62.7%-137.0%-223.0%-89.3%-51.6%-36.4%-41.2%-12.9%2.3%2.9%
Other Income 011011221023
Interest 21001200137
Depreciation 00000011515
Exceptional Items -4-200000000
Profit Before Tax -7-5-4-2-16-3-24-968
Tax 0000001002
Profit After Tax -7-5-4-2-16-3-25-966
PAT Margin (%) -277.0%-217.0%-191.0%-90.1%-171.0%-27.0%-40.7%-12.5%3.8%2.6%
Adjusted EPS (₹)-37.5-27.5-22.7-10.3-74.1-11.8-114.0-38.30.50.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 131132115951791773874691,1011,111
Share Capital 012121200002424
Reserves 130120103831791763874681,0781,087
Minority Interest0000000000
Debt8434343000000
Long Term Debt0434343000000
Short Term Debt8000000000
Trade Payables11113512613
Others Liabilities 7122644710287781150
Total Liabilities 1461871851831891924165481,1871,274

Fixed Assets

Gross Block22222192692201
Accumulated Depreciation11122123722
Net Fixed Assets11100072385179
CWIP 000000121618
Investments 144153177177181186381409418917
Inventories0000004547
Trade Receivables0000129122138
Cash Equivalents 03020411187790
Others Assets14443231263625
Total Assets 1461871851831891924165481,1871,274

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -2-5-4-2-1-13-6-1811
PBT -7-5-4-2-16-3-24-968
Adjustment 0-1-1012031813
Changes in Working Capital -031021-5-6-232
Tax Paid 0-3-102010-2-2
Cash Flow From Investing Activity 2-11-240-2-3-197-15-63632
Capex 000000-3-12-37-61
Net Investments 00000000-599543
Others 1-11-240-2-3-194-20-451
Cash Flow From Financing Activity -246007020497569-8
Net Proceeds from Shares 040070105941
Net Proceeds from Borrowing 04300000000
Interest Paid -2-1000000-3-7
Dividend Paid 0000000000
Others 00000020397-23-3
Net Cash Flow -230-28-14-41076-8635
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-5.29-4.15-3.86-2.1-12.34-1.44-8.83-20.710.5
ROCE (%)-3.52-2.56-2.5-1.27-2.29-1.39-8.3-1.751.011.25
Asset Turnover Ratio0.020.010.010.010.050.050.20.150.180.19
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/A-31.83
Working Capital Days
Receivable Days19263122125131523847
Inventory Days17171922571223108
Payable Days00000027131221

Medplus Health Services Ltd Stock News

Medplus Health Services Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Medplus Health Servi on 28-Mar-2024 13:30 is ₹689.5.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 13:30 the market cap of Medplus Health Servi stood at ₹8,182.9.
The latest P/E ratio of Medplus Health Servi as of 28-Mar-2024 13:30 is 0.00.
The latest P/B ratio of Medplus Health Servi as of 28-Mar-2024 13:30 is 7.07.
The 52-week high of Medplus Health Servi is ₹977.5 and the 52-week low is ₹598.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medplus Health Servi is ₹405.6 ( Cr.) .

About Medplus Health Services Ltd

Medplus Health Services offers a wide range of products, including (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company was founded in 2006 by Gangadi Madhukar Reddy, its Managing Director and Chief Executive Officer, with the vision to set up a trusted pharmacy retail brand that offers genuine medicines and delivers better value to the customer by reducing inefficiencies in the supply chain using technology.

The company employs a data analytics driven cluster-based approach to its store network expansion, whereby it first achieve high store density in a densely-populated residential area within a target city before expanding its store network in the surrounding areas within that city, followed by expansion into other adjacent cities. Its cluster-based approach to store network expansion is also driven by its understanding of the catchment demographics, market dynamics, and its ability to support store expansion with back-end infrastructure, such as warehouses and distribution centres. This approach and understanding allow it to (i) create brand visibility within the cities where it operate, through focused implementation of marketing and advertising initiatives, (ii) increase its market share in the cities where it operate, (iii) replicate its growth model in adjacent underserved cities and towns, as it develop its presence in those clusters, and (iv) generate cost efficiencies due to operating leverage achieved in its supply chain and inventory management. It has a streamlined and methodical store opening process, and dedicated operations and business development teams at the area, city and state levels that would vet and approve the opening of new stores.

Business area of the company

MedPlus is one of India's leading healthcare companies with an ever-growing number of pharmacy stores, online pharmacy, path labs and optical services.

Awards, accreditations and recognitions

  • 2012: VC Circle Awards - Best VC-backed Healthcare Services Company.
  • 2017: Hans India - hmtv Business Excellence Award - Best in Retail category.

Major events and milestones

  • 2007: Pharmaceutica Ventures Limited invested Rs 800 million, by subscribing to 45,720 equity shares, Peepul Capital Fund II LLC invested Rs 226.33 million by subscribing to 30,000 equity shares of the Company and NEA-IndoUS Venture Capital LLC invested $5 million by subscribing to 11,620 equity shares of our Company (out of which 4,662 equity shares through conversion of Series A CCPS.)
  • 2012: EBITDA of the Company turned positive.
  • 2017: Gangadi Investments Private Limited acquired 122,347 equity shares, 12,000,000 unlisted redeemable preference shares and 42,847,000 non-convertible debentures from MKCP Direct Investments (Mauritius) IV Limited, MKCP Institutional Investor (Mauritius) III Limited, TVS Shriram Growth Fund IA and Indiaventure Trust -Fund I.
  • 2019: PI Opportunities Fund - I invested acquiring 22.21% stake of the Company as on date, pursuant to purchase of 21,233 equity shares.
  • 2021: Lavender Rose invested Rs 6.56 billion, acquiring a 24.58% stake of the Company as on date through primary and secondary transactions.
  • 2021: PI Opportunities Fund - I invested Rs 222.10 million by subscribing to 160,147 Series C2 CCPS.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.